I am a physician scientist in my fourth year of a combined pediatrics and medical genetics residency at Johns Hopkins. My clinical goals are to care for children with neurometabolic conditions, and I will continue my medical biochemical genetics fellowship training at Johns Hopkins in 2025. From a scientific perspective, I would like to study the underlying pathobiology of neurometabolic disorders, and endeavor to design novel therapies for these patients. My research interests are in leukodystrophy, lysosomal storage disorders (LSDs) and peroxisomal disorders. My PhD thesis was with Dr. Laura Feltri and Dr. Larry Wrabetz in the Hunter James Kelly Research Institute (HJKRI) at the University of Buffalo. My research focused on Krabbe Disease (KD), a leukodystrophy that typically affects infants 6 months old and rapidly progresses to death by three years of age. My work revealed novel aspects of KD pathogenesis regarding cellular, temporal and biochemical causes of disease mechanism in a newly developed murine model of KD. Our work also has impact for other LSDs, specifically relating to mechanisms underlying the benefit and limitations of hematopoietic stem cell therapy and enzyme replacement therapy. Recently, I have joined the lab of Dr. Ali Fatemi, chair for pediatric neurology at the Kennedy Krieger Institute. Dr. Fatemi is a physician scientist that studies leukodystrophy, focusing on translational and therapeutic interventions including cell-based therapies, genetic therapies and small molecules. My current research project includes myelin lipid catabolism and inflammation in adrenoleukodystrophy.